Glycopyranosyl lipid adjuvant (Revelation Biosciences)

N/A

Report date: 2025/08/13 13:36:00
NME

Base Information

Drug NameGlycopyranosyl lipid adjuvant (Revelation Biosciences)
Drug Alias NameGeminiGlucopyranosyl Lipid APhosphorylated hexaacylated disaccharideSynthetic monophosphoryl Lipid APhosphorylated hexaacyl disaccharide +[13] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll like receptor 4 agonists
TargetsToll like receptor 4
Therapy Area/IndicationsInfluenza A virus infectionsMyocarditisRenal Insufficiency, Chronic +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesVanderbilt UniversityRevelation Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesRevelation Biosciences Inc
Inactive CompaniesN/A
Active IndicationsInfluenza A virus infectionsMyocarditisRenal Insufficiency, Chronic +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A